The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-UK to reopen in stages after driving down S.African variant, Hancock says

Sun, 21st Feb 2021 12:02

(Writes through with variants, results)

By Kate Holton and Alistair Smout

LONDON, Feb 20 (Reuters) - Britain has started to drive down
cases of the more infectious South African variant of
coronavirus and will only emerge from lockdown in stages to make
sure that does not change, the country's health secretary said
on Sunday.

A day before Prime Minister Boris Johnson sets out his plan
to ease restrictions in England, Hancock said there was also
early data showing that the faster-than-expected vaccine rollout
was reducing transmissions and easing pressure on hospitals.

Britain has the world's fifth-worst official COVID-19 death
toll, with 120,365 fatalities, but an early drive to secure mass
vaccine supplies means one in three adults has now had a first
shot and daily death rates have started to fall.

Hancock said in total the United Kingdom had recorded around
300 cases of the more infectious South African variant of the
disease that causes COVID-19.

"But most of those are now historic cases and from over a
month ago," he told the BBC's Andrew Marr show. "The latest data
shows that there's around a dozen new ones, so a much, much
smaller number."

England has also introduced hotel quarantines to prevent
variants from travelling from abroad.

So far, Britain has given a first dose of a vaccine to 17.2
million people, over a quarter of its 67 million population and
behind only Israel and the United Arab Emirates in vaccines per
head of population.

The government said on Sunday that all adults in Britain
would be offered a first shot by the end of July, with a target
to give a first dose to all over-50s by April 15.

But despite the improving picture, Hancock and leading
epidemiologist John Edmunds said the restrictions must be eased
gently and in stages, to see what impact the increased movement
of people has on the virus.

Hancock suggested each easing could require a couple of
weeks to detect the impact, before another part of the economy
can reopen. Schools are expected to return first in early March.

Edmunds said it was difficult to say how widespread the
South African variant was but that, like the rest of the
pandemic, it was being held in place by the lockdown.

"The risk comes when we release the lockdown," he said,
adding that allowing the virus to circulate in younger healthier
people could lead to further mutations that undermine the
vaccine programme.

Johnson will set out his thinking on the easing of lockdown
on Monday. Despite pressure from a section of lawmakers in his
party who have been shocked by the 10% contraction of the
economy in 2020, the prime minister is expected to be wary.

"There should be no doubt - the route out of lockdown will
be cautious and phased, as we all continue to protect ourselves
and those around us," Johnson said in a statement.

(
Editing by Ros Russell and Emelia Sithole-Matarise)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.